Article info

Original research
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Authors

  1. Correspondence to Professor Giorgio Stassi, Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy; giorgio.stassi{at}unipa.it; Professor Ruggero De Maria, Institute of General Pathology, Università Cattolica del Sacro Cuore, Rome, Italy; ruggero.demaria{at}unicatt.it
View Full Text

Citation

Mangiapane LR, Nicotra A, Turdo A, et al
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Publication history

  • Received November 8, 2020
  • Revised December 15, 2020
  • Accepted December 18, 2020
  • First published January 12, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.